These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients. Szczepanik AB, Sikorska A, Slomkowski M, Konopka L. Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915 [Abstract] [Full Text] [Related]
6. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients. Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR, Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP. Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390 [Abstract] [Full Text] [Related]
11. Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center. Ismet A, Irfan K, Emin K, AlI EM, Ramazan U, Mustafa B, Onur O. Clin Lab Haematol; 2004 Jun; 26(3):211-4. PubMed ID: 15163320 [Abstract] [Full Text] [Related]
13. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura? Cooper N, Evangelista ML, Amadori S, Stasi R. Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569 [Abstract] [Full Text] [Related]